Martin Mäser

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

Amany K. Elshorbagy, Alexander R.M. Lyons, Antonio J. Vallejo‐Vaz, Christophe A. T. Stevens et autres

BACKGROUND: Statins are the cornerstone treatment for patients with heterozygous familial hypercholesterolaemia but research suggests it could increase the risk of type 2 diabetes in the general population. A low prevalence of type 2 diabetes was reported in some familial hypercholesterolaemia cohorts, …

Variant-specific LDL-cholesterol patterns and risk of atherosclerotic cardiovascular disease in heterozygous FH: Insights from the Austrian FH-Registry

Reinhold Innerhofer, Christoph F. Ebenbichler, Margot Baumgartner-Kaut, Harald Esterbauer et autres

at, de (code pays fourni par la source)

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

Janneke W.C.M. Mulder, Tycho R. Tromp, Mutaz Al-Khnifsawi, Dirk Jacobus Blom et autres

Importance: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic condition characterized by extremely increased low-density lipoprotein (LDL) cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Heterozygous familial hypercholesterolemia (HeFH) is more common than HoFH, and women with HeFH are diagnosed later and …

nl, iq, Afrique du Sud, pl, us, it, fr, vn, cn, gb (code pays fourni par la source)

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe A. T. Stevens, Julia Brandts et autres

BACKGROUND: Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults with familial hypercholesterolaemia were diagnosed before age 18 years via current diagnostic approaches, which are derived from observations in adults. We aimed to characterise …

gb (code pays fourni par la source)

Characteristics and management of individuals with familial hypercholesterolemia in Austria – Data from the national FH-registry

R. Innerhofer, Christoph F. Ebenbichler, Margot Baumgartner-Kaut, Harald Esterbauer et autres

at (code pays fourni par la source)

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh, Antonio J. Vallejo‐Vaz et autres

nl, sg, es, gb, cz, it, jp, Afrique du Sud, us (code pays fourni par la source)

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe A. T. Stevens, Alexander R.M. Lyons, Kanika Dharmayat et autres

se, gb (code pays fourni par la source)

Preliminary Results from an International Registry on LDL-Apheresis in Children with Homozygous Hypercholesterolemia

Ilse K. Luirink, Éric Bruckert, Eldad J. Dann, Susanne Greber‐Platzer et autres

fr, il, at, es, de (code pays fourni par la source)

Genetic characterization of Panton–Valentine leukocidin-producing methicillin-resistant Staphylococcus aureus in Western Austria

Michael Berktold, Katharina Grif, Martin Mäser, Wolfgang Witte et autres

at, de (code pays fourni par la source)